APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Female Reproductive Digital Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Female Reproductive Digital Therapy Market Outlook and Growth Opportunities 2026

Report ID 17413940043 May 2026174 pages

Choose your research edition.

Industry ResearchFemale Reproductive Digital Therapy Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Reproductive Digital Therapy Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Female Reproductive Digital Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Reproductive Digital Therapy Market Outlook and Growth Opportunities 2026174 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Reproductive Digital Therapy Market Analysis and Forecast 2026-2032252 pages · $4,950 USD

Market perspective

The global Female Reproductive Digital Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Female Reproductive Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Female Reproductive Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female Reproductive Digital Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Female Reproductive Digital Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Female Reproductive Digital Therapy market include SWORD Health, Renovia, JOGO Health and Mevixaga, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Female Reproductive Digital Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Female Reproductive Digital Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Female Reproductive Digital Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Female Reproductive Digital Therapy market.

Female Reproductive Digital Therapy Segment by Company

SWORD Health

Renovia

JOGO Health

Mevixaga

Female Reproductive Digital Therapy Segment by Type

Mobile APP

Probe

Female Reproductive Digital Therapy Segment by Application

Pelvic Pain

Urinary Incontinence

Pelvic Organ Prolapse

Urinary Dysfunction

Others

Female Reproductive Digital Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Female Reproductive Digital Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Female Reproductive Digital Therapy key companies, revenue, market share, and recent developments.

3. To split the Female Reproductive Digital Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Female Reproductive Digital Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Female Reproductive Digital Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Female Reproductive Digital Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Reproductive Digital Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Reproductive Digital Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Reproductive Digital Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Female Reproductive Digital Therapy industry.

Chapter 3: Detailed analysis of Female Reproductive Digital Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Female Reproductive Digital Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Female Reproductive Digital Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Female Reproductive Digital Therapy Industry Trends Table 2. Female Reproductive Digital Therapy Industry Drivers Table 3. Female Reproductive Digital Therapy Industry Opportunities and Challenges Table 4. Female Reproductive Digital Therapy Industry Restraints Table 5. Global Female Reproductive Digital Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Female Reproductive Digital Therapy Revenue Share by Company (2021-2026) Table 7. Global Female Reproductive Digital Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Female Reproductive Digital Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Female Reproductive Digital Therapy Company, Product Type & Application Table 10. Global Female Reproductive Digital Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Female Reproductive Digital Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mobile APP Table 15. Significant Companies of Probe Table 16. Global Female Reproductive Digital Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Female Reproductive Digital Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Female Reproductive Digital Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Female Reproductive Digital Therapy Sales Value Share by Type (2021-2026) Table 20. Global Female Reproductive Digital Therapy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pelvic Pain Table 22. Significant Companies of Urinary Incontinence Table 23. Significant Companies of Pelvic Organ Prolapse Table 24. Significant Companies of Urinary Dysfunction Table 25. Significant Companies of Others Table 26. Global Female Reproductive Digital Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Female Reproductive Digital Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Female Reproductive Digital Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Female Reproductive Digital Therapy Sales Value Share by Application (2021-2026) Table 30. Global Female Reproductive Digital Therapy Sales Value Share by Application (2027-2032) Table 31. Global Female Reproductive Digital Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Female Reproductive Digital Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Female Reproductive Digital Therapy Sales Value Share by Region (2021-2026) Table 34. Global Female Reproductive Digital Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Female Reproductive Digital Therapy Sales Value Share by Region (2027-2032) Table 36. Global Female Reproductive Digital Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Female Reproductive Digital Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Female Reproductive Digital Therapy Sales Value Market Share by Country (2021-2026) Table 39. Global Female Reproductive Digital Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Female Reproductive Digital Therapy Sales Value Market Share by Country (2027-2032) Table 41. SWORD Health Company Information Table 42. SWORD Health Business Overview Table 43. SWORD Health Female Reproductive Digital Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. SWORD Health Female Reproductive Digital Therapy Product Portfolio Table 45. SWORD Health Recent Development Table 46. Renovia Company Information Table 47. Renovia Business Overview Table 48. Renovia Female Reproductive Digital Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Renovia Female Reproductive Digital Therapy Product Portfolio Table 50. Renovia Recent Development Table 51. JOGO Health Company Information Table 52. JOGO Health Business Overview Table 53. JOGO Health Female Reproductive Digital Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. JOGO Health Female Reproductive Digital Therapy Product Portfolio Table 55. JOGO Health Recent Development Table 56. Mevixaga Company Information Table 57. Mevixaga Business Overview Table 58. Mevixaga Female Reproductive Digital Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Mevixaga Female Reproductive Digital Therapy Product Portfolio Table 60. Mevixaga Recent Development Table 61. Research Programs/Design for This Report Table 62. Authors List of This Report Table 63. Secondary Sources Table 64. Primary Sources List of Figures Figure 1. Female Reproductive Digital Therapy Product Image Figure 2. Global Female Reproductive Digital Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female Reproductive Digital Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Female Reproductive Digital Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mobile APP Image Figure 8. Probe Image Figure 9. Global Female Reproductive Digital Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Female Reproductive Digital Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Female Reproductive Digital Therapy Sales Value Share by Type (2021-2032) Figure 12. Pelvic Pain Image Figure 13. Urinary Incontinence Image Figure 14. Pelvic Organ Prolapse Image Figure 15. Urinary Dysfunction Image Figure 16. Others Image Figure 17. Global Female Reproductive Digital Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Female Reproductive Digital Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Female Reproductive Digital Therapy Sales Value Share by Application (2021-2032) Figure 20. Global Female Reproductive Digital Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Female Reproductive Digital Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Female Reproductive Digital Therapy Sales Value (2021-2032) & (US$ Million) Figure 23. North America Female Reproductive Digital Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Female Reproductive Digital Therapy Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Female Reproductive Digital Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Female Reproductive Digital Therapy Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Female Reproductive Digital Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Female Reproductive Digital Therapy Sales Value (2021-2032) & (US$ Million) Figure 29. South America Female Reproductive Digital Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Female Reproductive Digital Therapy Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Female Reproductive Digital Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Mobile APP
  • Probe
Applications
  • Pelvic Pain
  • Urinary Incontinence
  • Pelvic Organ Prolapse
  • Urinary Dysfunction
  • Others
Companies covered
  • SWORD Health
  • Renovia
  • JOGO Health
  • Mevixaga

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Female Reproductive Digital Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Female Reproductive Digital Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Female Reproductive Digital Therapy Market Dynamics
  1. 2.1 Female Reproductive Digital Therapy Industry Trends
  2. 2.2 Female Reproductive Digital Therapy Industry Drivers
  3. 2.3 Female Reproductive Digital Therapy Industry Opportunities and Challenges
  4. 2.4 Female Reproductive Digital Therapy Industry Restraints
3 Female Reproductive Digital Therapy Market by Company
  1. 3.1 Global Female Reproductive Digital Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Female Reproductive Digital Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Female Reproductive Digital Therapy Company Ranking (2024-2026)
  4. 3.4 Global Female Reproductive Digital Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Female Reproductive Digital Therapy Company Product Type and Application
  6. 3.6 Global Female Reproductive Digital Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Female Reproductive Digital Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Female Reproductive Digital Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Female Reproductive Digital Therapy Market by Type
  1. 4.1 Female Reproductive Digital Therapy Type Introduction
  2. 4.1.1 Mobile APP
  3. 4.1.2 Probe
  4. 4.2 Global Female Reproductive Digital Therapy Sales Value by Type
  5. 4.2.1 Global Female Reproductive Digital Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Female Reproductive Digital Therapy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Female Reproductive Digital Therapy Sales Value Share by Type (2021-2032)
5 Female Reproductive Digital Therapy Market by Application
  1. 5.1 Female Reproductive Digital Therapy Application Introduction
  2. 5.1.1 Pelvic Pain
  3. 5.1.2 Urinary Incontinence
  4. 5.1.3 Pelvic Organ Prolapse
  5. 5.1.4 Urinary Dysfunction
  6. 5.1.5 Others
  7. 5.2 Global Female Reproductive Digital Therapy Sales Value by Application
  8. 5.2.1 Global Female Reproductive Digital Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Female Reproductive Digital Therapy Sales Value by Application (2021-2032)
  10. 5.2.3 Global Female Reproductive Digital Therapy Sales Value Share by Application (2021-2032)
6 Female Reproductive Digital Therapy Regional Value Analysis
  1. 6.1 Global Female Reproductive Digital Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Female Reproductive Digital Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Female Reproductive Digital Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Female Reproductive Digital Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Female Reproductive Digital Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Female Reproductive Digital Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Female Reproductive Digital Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Female Reproductive Digital Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Female Reproductive Digital Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Female Reproductive Digital Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Female Reproductive Digital Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Female Reproductive Digital Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Female Reproductive Digital Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Female Reproductive Digital Therapy Sales Value Share by Country, 2025 VS 2032
7 Female Reproductive Digital Therapy Country-level Value Analysis
  1. 7.1 Global Female Reproductive Digital Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Female Reproductive Digital Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Female Reproductive Digital Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Female Reproductive Digital Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Female Reproductive Digital Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Female Reproductive Digital Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Female Reproductive Digital Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SWORD Health
  2. 8.1.1 SWORD Health Company Information
  3. 8.1.2 SWORD Health Business Overview
  4. 8.1.3 SWORD Health Female Reproductive Digital Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SWORD Health Female Reproductive Digital Therapy Product Portfolio
  6. 8.1.5 SWORD Health Recent Developments
  7. 8.2 Renovia
  8. 8.2.1 Renovia Company Information
  9. 8.2.2 Renovia Business Overview
  10. 8.2.3 Renovia Female Reproductive Digital Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Renovia Female Reproductive Digital Therapy Product Portfolio
  12. 8.2.5 Renovia Recent Developments
  13. 8.3 JOGO Health
  14. 8.3.1 JOGO Health Company Information
  15. 8.3.2 JOGO Health Business Overview
  16. 8.3.3 JOGO Health Female Reproductive Digital Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 JOGO Health Female Reproductive Digital Therapy Product Portfolio
  18. 8.3.5 JOGO Health Recent Developments
  19. 8.4 Mevixaga
  20. 8.4.1 Mevixaga Company Information
  21. 8.4.2 Mevixaga Business Overview
  22. 8.4.3 Mevixaga Female Reproductive Digital Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mevixaga Female Reproductive Digital Therapy Product Portfolio
  24. 8.4.5 Mevixaga Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst